134 companies

GenMont Biotech Incorporation

Market Cap: NT$1.7b

Engages in the research and development, manufacture, and sale of various probiotic health products in Taiwan.

3164

NT$19.95

7D

-1.0%

1Y

-11.5%

Pet Pharm Biotech

Market Cap: NT$3.7b

Manufactures and sells pharmaceutical products.

7762

NT$73.80

7D

19.4%

1Y

127.8%

Bio Preventive Medicine

Market Cap: NT$1.3b

Bio Preventive Medicine Corp, a clinical-staged biotech company, focusing on early detection and prevention of diseases.

6810

NT$26.00

7D

-4.1%

1Y

-15.9%

Lotus Pharmaceutical

Market Cap: NT$52.7b

Engages in the research and development, manufacture, and sale of generic pharmaceutical products in Taiwan, South Korea, the United States, and internationally.

1795

NT$200.50

7D

-9.5%

1Y

-27.1%

Welgene BiotechLtd

Market Cap: NT$498.7m

Provides genetic testing services.

6661

NT$21.40

7D

6.5%

1Y

-24.9%

Energenesis BiomedicalLTD

Market Cap: NT$5.3b

Operates in the biomedicine industry in Taiwan.

6657

NT$59.90

7D

4.2%

1Y

15.0%

Medigen Biotechnology

Market Cap: NT$4.2b

A biopharmaceutical company, engages in the research and development of new drugs and vaccines, cytotherapy, advanced nucleic acid testing, generic drugs, aesthetic medicine, and vaccine-related products in Taiwan.

3176

NT$30.40

7D

-1.9%

1Y

-21.0%

Gwo Xi Stem Cell Applied Technology

Market Cap: NT$2.2b

Develops stem cell medicines for patients with unmet medical needs.

6704

NT$22.65

7D

-1.5%

1Y

-31.4%

Taho Pharmaceuticals

Market Cap: NT$5.6b

A pharmaceutical company, develops products using transdermal and transmucosal systems in Taiwan.

6467

NT$108.00

7D

14.4%

1Y

n/a

Tanvex BioPharma

Market Cap: NT$13.1b

A biopharmaceutical company, researches, develops, manufactures, and sells biosimilar products in Taiwan and the United States.

6541

NT$55.00

7D

3.2%

1Y

5.8%

Lin BioScience

Market Cap: NT$13.3b

A drug development company, develops therapies for oncology, ophthalmology, and metabolic diseases.

6696

NT$161.00

7D

-0.6%

1Y

74.2%

Great Novel Therapeutics Biotech & Medicals

Market Cap: NT$1.5b

Engages in the development of drugs for the treatment of advanced and refractory cancers.

7427

NT$33.55

7D

-5.0%

1Y

-16.7%

MegaPro Biomedical

Market Cap: NT$1.2b

A biotech company, focuses on the development of nano drugs.

6827

NT$18.50

7D

5.1%

1Y

-2.6%

SYN-TECH Chem. & Pharm

Market Cap: NT$3.3b

Manufactures and sells active pharmaceutical ingredients (APIs) in Taiwan, Asia, Europe, the Americas, and internationally.

1777

NT$73.60

7D

0.3%

1Y

-19.3%

3D Global Biotech

Market Cap: NT$3.1b

Develops medical materials for human body reconstruction in China.

6808

NT$40.00

7D

-13.6%

1Y

12.7%

Steminent Biotherapeutics

Market Cap: NT$2.0b

A stem cell research and development company, develops and manufactures novel cellular therapeutics for the treatment of diseases with unmet or under-served medical needs.

7729

NT$36.25

7D

27.9%

1Y

59.3%

Enimmune

Market Cap: NT$1.2b

Operates as a biopharmaceutical Research and development, and marketing company in Taiwan.

6564

NT$16.60

7D

0.3%

1Y

-51.7%

TaiMed Biologics

Market Cap: NT$21.8b

A biotechnology company, develops, manufactures, and commercializes drugs for the treatment and prevention of infectious diseases.

4147

NT$79.70

7D

1.1%

1Y

-1.5%

BioLASCO Taiwan

Market Cap: NT$836.2m

Provides bio-materials and surgical services in Taiwan and internationally.

6662

NT$32.65

7D

0%

1Y

-10.2%

Golden Biotechnology

Market Cap: NT$1.8b

Operates as a drug discovery and healthy food supplement manufacturing company in Taiwan, the United States, Japan, China, Korea, and Singapore.

4132

NT$11.10

7D

-1.8%

1Y

-46.2%

Handa Pharmaceuticals

Market Cap: NT$12.8b

A specialty pharmaceutical company, focuses on the development of drugs for various diseases in the United States.

6620

NT$80.80

7D

-1.3%

1Y

-7.3%

BioGend Therapeutics

Market Cap: NT$4.5b

Researches, develops, and sells orthopedic medical equipment and related products.

6733

NT$36.55

7D

22.7%

1Y

8.5%

Cenra

Market Cap: NT$5.0b

Engages in the research and development, manufacture, and sale of generic pharmaceutical and healthcare products for humans and animals.

3716

NT$34.40

7D

0%

1Y

n/a

TaiGen Biopharmaceuticals Holdings

Market Cap: NT$6.5b

A pharmaceutical company, develops novel therapeutics for transformative diseases worldwide.

4157

NT$9.12

7D

10.8%

1Y

-37.3%

Genovate Biotechnology

Market Cap: NT$2.1b

Engages in the research, development, manufacture, production, and sale of products to prevent and treat diseases caused by viruses and bacteria in Taiwan.

4130

NT$18.70

7D

0.3%

1Y

-15.3%

Nang Kuang Pharmaceutical

Market Cap: NT$3.6b

Manufactures, processes, trades in, imports, and exports pharmaceuticals and medical devices in Taiwan, China, Japan, the United States, and internationally.

1752

NT$35.60

7D

0.8%

1Y

-21.8%

Page 4 of 4